These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2532842)

  • 1. Immunopathogenesis and immunocorrection of psoriasis.
    Rubins AY; Wekhsler HM; Merson AG; Guseva LN; Grant HY; Poluektova LE; Gipsh NM; Rubine GY
    Acta Derm Venereol Suppl (Stockh); 1989; 146():13-5. PubMed ID: 2532842
    [No Abstract]   [Full Text] [Related]  

  • 2. [Determination of the level of circulating lymphocyte subpopulations using monoclonal antibodies in the blood of psoriasis patients and its alteration during immunocorrective therapy].
    Riabinina ME; Berenbeĭn BA; Slavina EG
    Vestn Dermatol Venerol; 1986; (1):18-21. PubMed ID: 2938359
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunopathogenesis of psoriasis: focus on natural killer T cells.
    Peternel S; Kastelan M
    J Eur Acad Dermatol Venereol; 2009 Oct; 23(10):1123-7. PubMed ID: 19453772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Imbalance of T lymphocyte subpopulations in patients with psoriasis and its immune correction].
    Rubins AJ; Mashkilleysson AL; Merson AG; Gipsh NM
    Z Hautkr; 1987 Mar; 62(6):497-501. PubMed ID: 2954313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunopathogenesis and immunotherapy of psoriasis.
    Griffiths TW; Griffiths CE; Voorhees JJ
    Dermatol Clin; 1995 Oct; 13(4):739-49. PubMed ID: 8785879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinico-immunological correlations in psoriatic arthritis based on data from determining cellular (T- and B-lymphocytes) and humoral (IgG, IgA and IgM) immunity factors].
    Nikulin NK; Starostina ZD; Komarova VD
    Vestn Dermatol Venerol; 1981 Sep; (9):10-4. PubMed ID: 6975543
    [No Abstract]   [Full Text] [Related]  

  • 7. Increased expression of the natural killer cell inhibitory receptor CD94/NKG2A and CD158b on circulating and lesional T cells in patients with chronic plaque psoriasis.
    Liao YH; Jee SH; Sheu BC; Huang YL; Tseng MP; Hsu SM; Tsai TF
    Br J Dermatol; 2006 Aug; 155(2):318-24. PubMed ID: 16882169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of different immunomodulators on the subpopulations of immunocompetent cells. The immunomodulating therapy of respiratory diseases].
    Sil'vestrov VP; Karaulov AV; Martsinovskiĭ VIu; Likov VF
    Ter Arkh; 1985; 57(1):70-5. PubMed ID: 3872483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of thymalin on indices of immunity and hemostasis in patients with disseminated forms of psoriasis].
    Isaeva MP; Budazhabon GB; Kuznik BI
    Vestn Dermatol Venerol; 1989; (10):42-3. PubMed ID: 2609748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Natural killer activity of peripheral blood in psoriasis patients].
    Rubinsk AIa; Mashkilleĭson AL; Veksler KhM; Graudinia ZhP; Poluektova LE
    Vestn Dermatol Venerol; 1985 Dec; (12):8-10. PubMed ID: 4090701
    [No Abstract]   [Full Text] [Related]  

  • 11. [Normalization of immune function following therapy with Cantastim in a case of chronic T-cell lymphatic leukemia (CTLL)].
    Olinescu A; Hristescu S; Sălăgeanu A; Petrovici A; Grigoriu G
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1988; 33(3):281-8. PubMed ID: 3249900
    [No Abstract]   [Full Text] [Related]  

  • 12. [Psoriasis in HTLV-III-induced immunologic defect--status of cellular immunity and immunohistologic findings].
    Steigleder GK; Rasokat H; Wemmer U
    Z Hautkr; 1986 Dec; 61(23):1671-8. PubMed ID: 2949441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cellular and humoral immunity in erysipelatous inflammation].
    Frolov VM; Rychnev VE; Azarin IG; Peresadin NA
    Vrach Delo; 1983 Dec; (12):97-100. PubMed ID: 6230799
    [No Abstract]   [Full Text] [Related]  

  • 14. [Metastasis. Natural history and therapeutic data].
    Scolozzi R; Boccafogli A; Furlani RF; Vicentini L
    Recenti Prog Med; 1982 Apr; 72(4):446-81. PubMed ID: 6216563
    [No Abstract]   [Full Text] [Related]  

  • 15. Suppression of natural killer activity and antibody-dependent cellular cytotoxicity by cultured human lymphocytes.
    Nair MP; Schwartz SA
    J Immunol; 1981 Jun; 126(6):2221-9. PubMed ID: 6453160
    [No Abstract]   [Full Text] [Related]  

  • 16. On the immunopathogenesis of psoriasis.
    Jablonska S; Majewski S
    Arch Dermatol; 2001 Feb; 137(2):229-31. PubMed ID: 11176704
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of treatment on the immunological indices in psoriasis].
    Shaposhnikov OK; Stogov IuN; Bronovets VA; Domaseva TV
    Voen Med Zh; 1981 Jan; (1):37-9. PubMed ID: 7210557
    [No Abstract]   [Full Text] [Related]  

  • 18. [Depressor lymphocytes in bone allografting].
    Govallo VI; Khudaĭdatov IS
    Ortop Travmatol Protez; 1981 Apr; (4):41-4. PubMed ID: 6457266
    [No Abstract]   [Full Text] [Related]  

  • 19. [Indices of cellular and humoral immunity in hemosorption in patients with disseminated psoriasis].
    Evseev NG; Korotkiĭ NG; Krymkina TN; Koval'chuk LV; Molodenkov MN
    Vestn Dermatol Venerol; 1980 Aug; (8):9-12. PubMed ID: 7245894
    [No Abstract]   [Full Text] [Related]  

  • 20. Upregulation of Fas and downregulation of CD94/NKG2A inhibitory receptors on circulating natural killer cells in patients with new-onset psoriasis.
    Son SW; Kim EO; Ryu ES; Kim TJ; Kim JN; Choi JE; Kye YC; Lee KM
    Br J Dermatol; 2009 Aug; 161(2):281-8. PubMed ID: 19438461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.